| | | | | | | |
 | GILEAD SCIENCES, INC. | 0.43% | 1.58% | -13.95% | -8.02% | -7.52% | 78 370 |
| VERTEX PHARMACEUTICALS | 1.51% | 2.95% | 27.66% | 42.47% | 52.88% | 71 701 |
| REGENERON PHARMACEUTICALS, INC. | 0.54% | 1.84% | -5.37% | 9.46% | 90.93% | 64 391 |
 | WUXI APPTEC CO., LTD. | -0.70% | 7.38% | -14.46% | -35.79% | 175.22% | 44 027 |
| BIONTECH SE | 1.54% | 14.81% | -44.93% | -37.74% | --.--% | 34 504 |
 | GENMAB A/S | 0.76% | 5.02% | -14.11% | -12.91% | 87.16% | 20 806 |
 | ARGENX SE | 1.79% | 4.07% | 11.80% | 34.18% | 186.12% | 20 164 |
| BEIGENE, LTD. | -1.66% | 4.25% | -40.10% | -54.55% | 30.93% | 16 770 |
| NEUROCRINE BIOSCIENCES, INC. | 1.58% | 4.51% | 15.60% | 1.57% | 16.62% | 9 410 |
| LEGEND BIOTECH CORPORATION | 3.48% | 13.96% | 16.80% | 33.37% | --.--% | 8 396 |
| SAREPTA THERAPEUTICS, INC. | 3.21% | 12.82% | -14.41% | -2.22% | -49.28% | 6 744 |
| EXELIXIS, INC. | -0.72% | 2.97% | 13.73% | 15.82% | -2.71% | 6 668 |
| HALOZYME THERAPEUTICS, INC. | -1.09% | 0.04% | 12.61% | -1.05% | 163.56% | 6 238 |
| INTRA-CELLULAR THERAPIES, INC. | 5.58% | 7.44% | 11.41% | 46.69% | 349.23% | 5 500 |
| ASCENDIS PHARMA A/S | 1.13% | 9.88% | -29.98% | -29.84% | -18.19% | 5 257 |
| | | | | | | |
| | Moyenne | 1.16% | 6.23% | -4.51% | 0.09% | 82.69% | |
| | Moyenne pondérée par Capi. | 0.79% | 4.78% | -5.27% | 0.33% | 71.64% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
